At this year`s 14th Dresden Symposium on Autoantibodies the diagnostic relevance of anti-HNK-1 antibodies has been presented for the first time.
- info@buhlmannlabs.ch
- +41 61 487 12 12
Blog Archives
We are very pleased to announce the United States Food and Drug Administration (FDA) 510(k) clearance for the BÜHLMANN CALEX® Cap.
We created six new IBDoc® Portal Tutorial Videos to help Healthcare Professionals that start using IBDoc®.
Interview with Dr. Elodie Hanon from the Freeman Hospital in Newcastle about the evaluation of the BÜHLMANN fCAL® turbo on their Roche Cobas c702.
Social Links